From on Medscape

Coverage from the

Transcatheter Cardiovascular Therapeutics (TCT) 2023

October 23 - 26, 2023; San Francisco, California

October 23 - 26, 2023 San Francisco, California
  • TCT 2023 Trilogy TAVR Safe, Effective in Aortic Regurgitation The Trilogy transcatheter aortic valve replacement system was safe and effective for high-risk surgical patients with aortic regurgitation, improving LV remodeling and function, in the ALIGN-AR trial.
  • TCT 2023 TAVR With LAAO Non-inferior to TAVR Plus Medical Therapy Left atrial appendage occlusion in the same procedure with transcatheter aortic valve replacement proved non-inferior to TAVR plus medical therapy in AF and aortic stenosis, in the WATCH-TAVR study.

Conference News

Popular News from TCT 2022

Previous Coverage